These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1279828)

  • 1. [The pharmacodynamics of anti-arrhythmia preparations and their different combinations when administered intravenously].
    Abdalla A; Mazur NA; Iavorskaia NV; Kheĭmets GI; Chikovani SI; Potekhin EG
    Ter Arkh; 1992; 64(8):20-5. PubMed ID: 1279828
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacodynamics of the new anti-arrhythmia preparation bonnecor in patients with extrasystoles].
    Ol'binskaia LI; Rybakov MA; Sizova ZhM
    Farmakol Toksikol; 1990; 53(3):63-4. PubMed ID: 1696910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease].
    Dobrotvorskaia TE; Rybakova MK; Suprun EK; Arifullin ShS
    Ter Arkh; 1992; 64(12):30-2. PubMed ID: 1284005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spontaneous variability of ventricular arrhythmias and evaluation of antiarrhythmic drug efficacy--studies evaluating the correlation between ventricular ectopic beat frequency and heart rate].
    Ito M; Tsumabuki S; Maeda Y; Arita M
    Rinsho Byori; 1986 Aug; 34(8):939-48. PubMed ID: 2431174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
    Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
    Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug].
    Assmann I; Kassel P; von Knorre G
    Z Gesamte Inn Med; 1990 Dec; 45(23):703-8. PubMed ID: 1714669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimization of the use of etmozin in treating patients suffering from frequent ventricular extrasystole].
    Bugriĭ EM; Mazur NA; Pavlova TS; Dzhishambaev ED
    Ter Arkh; 1986; 58(6):62-5. PubMed ID: 2429379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 9. [Predicting changes in hemodynamics and anti-arrhythmic effectiveness of neogilurytmal].
    Nesvetov VN; Shpektor AV; Gorshkov VA
    Sov Med; 1987; (10):36-9. PubMed ID: 2447655
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the anti-arrhythmic activity of carbamazepine, novocainamide and obzidan in ventricular extrasystole].
    Logosha IuI; Kamalova EG; Khusainova FS
    Farmakol Toksikol; 1986; 49(6):71-3. PubMed ID: 2434357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late potentials in high resolution ECG in thyroid gland dysfunction].
    Schippinger W; Buchinger W; Schubert B; Költringer P; Eber O
    Acta Med Austriaca; 1995; 22(4):73-74. PubMed ID: 8835425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effectiveness of a combination of mexitil with etmozin, allapinin or quinidine in ventricular extrasystole].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 May; 66(5):57-60. PubMed ID: 2458502
    [No Abstract]   [Full Text] [Related]  

  • 15. [Safety of long-term therapy with a combination of various anti-arrhythmia agents].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Klin Med (Mosk); 1989 Mar; 67(3):79-82. PubMed ID: 2473246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations].
    Mazur NA; Kurbanov RD
    Ter Arkh; 1984; 56(9):67-70. PubMed ID: 6083611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
    Belogubets VI; Polevaia TIu; Afonskaia NI; Smetnev AS
    Ter Arkh; 1994; 66(8):32-4. PubMed ID: 7527162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-arrhythmic activity of atropine, ritmilen, obsidan and cordarone in patients with ventricular allorhythmia].
    Antiu'fev VF; Arkhipov MV
    Klin Med (Mosk); 1989 Jun; 67(6):112-7. PubMed ID: 2476585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The time characteristics of the chronotropic and anti-arrhythmia effects of kordaron].
    Antiuf'ev VF; Arkhipov MV
    Vrach Delo; 1991 Sep; (9):39-41. PubMed ID: 1722062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.